Status:
COMPLETED
Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea
Lead Sponsor:
Bulovka Hospital
Collaborating Sponsors:
Örebro University, Sweden
Conditions:
Gonorrhea
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
A non-inferiority, open-label, multicentre randomised controlled trial to compare two therapeutic regimens for the treatment of uncomplicated urogenital, rectal or pharyngeal gonorrhoea in men and wom...
Detailed Description
Non-inferiority, open-label, multicentre randomised clinical trial (RCT) compared two regimens for the treatment of uncomplicated urogenital, rectal or pharyngeal gonorrhoea in men and women between 1...
Eligibility Criteria
Inclusion
- uncomplicated urogenital, rectal or pharyngeal gonorrhoea diagnosed using the nucleic acid amplification test
Exclusion
- any antimicrobial treatment during the 4 weeks before study enrolment
- pregnancy or lactation
- autoimmune disease
- renal, hepatic or cardiac insufficiency
- immunosuppressive therapy
- allergy to cephalosporins, macrolides or doxycycline
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2022
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT06090565
Start Date
April 1 2021
End Date
December 22 2022
Last Update
October 23 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Venereology Prague, Medicentrum Beroun
Prague, Czechia, 15000
2
University Hospital Bulovka
Prague, Czechia, 18081